Amyloid-β(1-42) fibrillar precursors are optimal for inducing tumor necrosis factor-α production in the THP-1 human monocytic cell line

Biochemistry

Volumn 48, Issue 38, 2009, Pages 9011-9021

  Ajit, Deepa ^a   Udan, Maria L D ^a   Paranjape, Geeta ^a   Nichols, Michael R ^a  

^a UNIVERSITY OF MISSOURI ST LOUIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGREGATE MORPHOLOGY; ALZHEIMER'S DISEASE; CELLULAR RESPONSE; CONCENTRATION OF; CYTOKINES; FIBRIL FORMATION; FIBRILLAR STRUCTURES; IN-VITRO; IN-VIVO; INFLAMMATORY RESPONSE; INTERMEDIATE STAGE; MICROGLIA; MODEL SYSTEM; MONOCYTIC CELLS; PROINFLAMMATORY; PROINFLAMMATORY RESPONSE; STERILE WATER; STRUCTURAL POLYMORPHISMS; TUMOR NECROSIS FACTORS;

AMINES; ATOMIC FORCE MICROSCOPY; BODY FLUIDS; CELL CULTURE; CELL MEMBRANES; MACROPHAGES; OLIGOMERS; PEPTIDES; POLYMORPHISM; SIZE SEPARATION; TUMORS;

GLYCOPROTEINS;

AMYLOID BETA PROTEIN[1-42]; PROTEIN PRECURSOR; SODIUM HYDROXIDE; TUMOR NECROSIS FACTOR ALPHA; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA-PROTEIN (1-42); AUTACOID; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ARTICLE; ATOMIC FORCE MICROSCOPY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; INFLAMMATION; MICROGLIA; MONOCYTE; PRIORITY JOURNAL; PROTEIN AGGREGATION; SENILE PLAQUE; BIOSYNTHESIS; CELL LINE; CHEMISTRY; DRUG EFFECT; METABOLISM; PROTEIN QUATERNARY STRUCTURE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; CELL LINE; HUMANS; INFLAMMATION MEDIATORS; MICROSCOPY, ATOMIC FORCE; MONOCYTES; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; PROTEIN STRUCTURE, QUATERNARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349782469     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi9003777     Document Type: Article

References (52)

1. Selkoe, D. J. (2004) Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases. Nat. Cell Biol. 6, 1054-1061.
2. Selkoe, D. J. (1998) The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8, 447-453. (Pubitemid 28529718)
3. McGeer, P. L., Itagaki, S., Tago, H., and McGeer, E. G. (1987) Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci. Lett. 79, 195-200.
4. Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., and Hyman, B. T. (2008) Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer's disease. Nature 451, 720-724. (Pubitemid 351220570)
5. Dickson, D. W., Lee, S. C., Mattiace, L. A., Yen, S. H. C., and Brosnan, C. (1993) Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer disease. Glia 7, 75-83.
6. McGeer, E. G., and McGeer, P. L. (1998) The importance of inflammatory mechanisms in Alzheimer disease. Exp. Gerontol. 33, 371-378.
7. Golde, T. E. (2002) Inflammation takes on Alzheimer disease. Nat. Med. 8, 936-938.
8. Bacskai, B. J., Kajdasz, S. T., Christie, R. H., Carter, C., Games, D., Seubert, P., Schenk, D., and Hyman, B. T. (2001) Imaging of amyloid- β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nat. Med. 7, 369-372.
9. Harper, J. D., Wong, S. S., Lieber, C. M., and Lansbury, P. T. Jr. (1997) Observation of metastable Aβ amyloid protofibrils by atomic force microscopy. Chem. Biol. 4, 119-125.
10. Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M., and Teplow, D. B. (1997) Amyloid β-protein fibrillogenesis: Detection of a protofibrillar intermediate. J. Biol. Chem. 272, 22364-22372.
11. Harper, J. D., Wong, S. S., Lieber, C. M., and Lansbury, P. T. Jr. (1999) Assembly of Aβ amyloid peptides: An in vitro model for a possible early event in Alzheimer's disease. Biochemistry 38, 8972-8980. (Pubitemid 129515230)
12. Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., and Teplow, D. B. (1999) Amyloid β-protein fibrillogenesis: Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274, 25945-25952.
13. Stine, W. B. J., Dahlgren, K. N., Krafft, G. A., and LaDu, M. J. (2003) In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis. J. Biol. Chem. 278, 11612-11622.
14. Deshpande, A., Mina, E., Glabe, C., and Busciglio, J. (2006) Different conformations of amyloid β induce neurotoxicity by distinct mechanisms in human cortical neurons. J. Neurosci. 26, 6011-6018. (Pubitemid 44318367)
15. Lorenzo, A., and Yankner, B. A. (1994) β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. U.S.A. 91, 12243-12247.
16. Pike, C. J., Walencewicz, A. J., Glabe, C. G., and Cotman, C. W. (1991) In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563, 311-314.
17. Dahlgren, K. N., Manelli, A. M., Stine, W. B. Jr., Baker, L. K., Krafft, G. A., and LaDu, M. J. (2002) Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J. Biol. Chem. 277, 32046-32053.
18. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., and Selkoe, D. J. (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539. (Pubitemid 34288854)
19. Klegeris, A., Walker, D. G., and McGeer, P. L. (1997) Interaction of Alzheimer β-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-α. Brain Res. 747, 114-121. (Pubitemid 27063805)
20. Yates, S. L., Burgess, L. H., Kocsis-Angle, J., Antal, J. M., Dority, M. D., Embury, P. B., Piotrkowski, A. M., and Brunden, K. R. (2000) Amyloid β and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia. J. Neurochem. 74, 1017-1025. (Pubitemid 30104297)
21. Combs, C. K., Karlo, J. C., Kao, S. C., and Landreth, G. E. (2001) β- Amyloid stimulation of microglia and monocytes results in TNFα-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J. Neurosci. 21, 1179-1188.
22. Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., Migheli, A., Nawroth, P., Stern, D., and Schmidt, A. M. (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691. (Pubitemid 26282167)
23. Bamberger, M. E., Harris, M. E., McDonald, D. R., Husemann, J., and Landreth, G. E. (2003) A cell surface receptor complex for fibrillar β-amyloid mediates microglial activation. J. Neurosci. 23, 2665-2674. (Pubitemid 36418601)
24. Udan, M. L., Ajit, D., Crouse, N. R., and Nichols, M. R. (2008) Toll-like receptors 2 and 4 mediate Aβ(1-42) activation of the innate immune response in a human monocytic cell line. J. Neurochem. 104, 524-533.
25. Fassbender, K., Walter, S., Kuhl, S., Landmann, R., Ishii, K., Bertsch, T., Stalder, A. K., Muehlhauser, F., Liu, Y., Ulmer, A. J., Rivest, S., Lentschat, A., Gulbins, E., Jucker, M., Staufenbiel, M., Brechtel, K., Walter, J., Multhaup, G., Penke, B., Adachi, Y., Hartmann, T., and Beyreuther, K. (2004) The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J. 18, 203-205.
26. Walter, S., Letiembre, M., Liu, Y., Heine, H., Penke, B., Hao, W., Bode, B., Manietta, N., Walter, J., Schulz-Schuffer, W., and Fassbender, K. (2007) Role of the Toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cell. Physiol. Biochem. 20, 947-956.
27. El Khy, J., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., and Loike, J. D. (1996) Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature 382, 716-719. (Pubitemid 26282177)
28. Nichols, M. R., Moss, M. A., Reed, D.K., Lin, W. L., Mukhopadhyay, R., Hoh, J. H., and Rosenberry, T. L. (2002) Growth of β-amyloid-(1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy. Biochemistry 41, 6115-6127.
29. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
30. Nichols, M. R., Moss, M. A., Reed, D. K., Cratic-McDaniel, S., Hoh, J. H., and Rosenberry, T. L. (2005) Amyloid-β protofibrils differ from amyloid-β aggregates induced in dilute hexafluoroisopropanol in stability and morphology. J. Biol. Chem. 280, 2471-2480.
31. Parvathy, S., Rajadas, J., Ryan, H., Vaziri, S., Anderson, L., and Murphy, G. M. (2008) Aβ peptide conformation determines uptake and interleukin-1α expression by primary microglial cells. Neurobiol. Aging (in press).
32. Scudiero, D. A., Shoemaker, R. H., Paull, K. D., Monks, A., Tierney, S., Nofziger, T. H., Currens, M. J., Seniff, D., and Boyd, M. R. (1988) Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48, 4827-4833. (Pubitemid 18224442)
33. Grammas, P., and Ovase, R. (2001) Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol. Aging 22, 837-842. (Pubitemid 34066550)
34. Tarkowski, E., Andreasen, N., Tarkowski, A., and Blennow, K. (2003) Intrathecal inflammation precedes development of Alzheimer's disease. J. Neurol., Neurosurg. Psychiatry 74, 1200-1205.
35. Jarrett, J. T., and Lansbury, P. T. Jr. (1993) Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058.
36. Lashuel, H. A., and Grillo-Bosch, D. (2005) In vitro preparation of prefibrillar intermediates of amyloid-β and α-synuclein. Methods Mol. Biol. 299, 19-33.
37. Kayed, R., Head, E., Sarsoza, F., Saing, T., Cotman, C. W., Necula, M., Margol, L., Wu, J., Breydo, L., Thompson, J. L., Rasool, S., Gurlo, T., Butler, P., and Glabe, C. G. (2007) Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol. Neurodegener. 2, 18.
38. Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L. Jr., Baron, P., Villalba, M., Ferrari, D., and Rossi, F. (1995) Activation of micro-glial cells by β-amyloid protein and interferon-. Nature 374, 647-650.
39. Lorton, D., Kocsis, J. M., King, L., Madden, K., and Brunden, K. R. (1996) β-Amyloid induces increased release of interleukin-1β from lipopolysaccharide-activated human monocytes. J. Neuroimmunol. 67, 21-29. (Pubitemid 26245700)
40. Laferla, F. M., Green, K. N., and Oddo, S. (2007) Intracellular amyloid-β in Alzheimer's disease. Nat. Rev. Neurosci. 8, 499-509.
41. Tycko, R. (2003) Insights into the amyloid folding problem from solid-state NMR. Biochemistry 42, 3151-3159.
42. 10-35) fibril. J. Am. Chem. Soc. 122, 7883-7889.
43. 16-22, a seven-residue fragment of the Alzheimer's β-amyloid peptide, and structural characterization by solid state NMR. Biochemistry 39, 13748-13759.
44. Lansbury, P. T. Jr., Costa, P. R., Griffiths, J. M., Simon, E. J., Auger, M., Halverson, K. J., Kocisko, D. A., Hendsch, Z. S., Ashburn, T. T., Spencer, R. G., Tidor, B., and Griffin, R. G. (1995) Structural model for the β-amyloid fibril based on interstrand alignment of an anti-parallel-sheet comprising a C-terminal peptide. Nat. Struct. Biol. 2, 990-998.
45. Petkova, A. T., Buntkowsky, G., Dyda, F., Leapman, R. D., Yau, W. M., and Tycko, R. (2004) Solid state NMR reveals a pH-dependent antiparallel β-sheet registry in fibrils formed by a β-amyloid peptide. J. Mol. Biol. 335, 247-260.
46. Petkova, A. T., Leapman, R. D., Guo, Z., Yau, W. M., Mattson, M. P., and Tycko, R. (2005) Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science 307, 262-265. (Pubitemid 40116242)
47. O'Nuallain, B., and Wetzel, R. (2002) Conformational Abs recognizing a generic amyloid fibril epitope. Proc. Natl. Acad. Sci. U.S.A. 99, 1485-1490.
48. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., and Glabe, C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489. (Pubitemid 36444329)
49. Haass, C., and Selkoe, D. J. (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid β-peptide. Nat. Rev. Mol. Cell Biol. 8, 101-112.
50. Terry, R. D., Gonatas, N. K., and Weiss, M. (1964) Ultrastructural studies in Alzheimer's presenile dementia. Am. J. Pathol. 44, 269-297.
51. Koffie, R. M., Meyer-Luehmann, M., Hashimoto, T., Adams, K. W., Mielke, M. L., Garcia-Alloza, M., Micheva, K. D., Smith, S. J., Kim, M. L., Lee, V. M., Hyman, B. T., and Spires-Jones, T. L. (2009) Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc. Natl. Acad. Sci. U.S.A. 106, 4012-4017.
52. Lee, E. B., Leng, L. Z., Zhang, B., Kwong, L., Trojanowski, J. Q., Abel, T., and Lee, V. M. (2006) Targeting amyloid-β peptide (Aβ) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Aβ precursor protein (APP) transgenic mice. J. Biol. Chem. 281, 4292-4299.